Evidence Supporting the Use of Recombinant Activated Factor VII in Congenital Bleeding Disorders
Author(s) -
Pär I. Johansson,
Sisse Rye Ostrowski
Publication year - 2011
Publication title -
european oncology and haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.116
H-Index - 6
eISSN - 2045-5283
pISSN - 2045-5275
DOI - 10.17925/eoh.2011.07.01.71
Subject(s) - medicine , adverse effect , haemophilia , thrombelastography , factor viia , randomized controlled trial , recombinant factor viia , clinical trial , thrombin generation , thrombin , surgery , anesthesia , coagulation , tissue factor , platelet
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom